Skip to main content
. 2021 Apr 8;23(4):540–548. doi: 10.1007/s12017-021-08656-0

Fig. 2.

Fig. 2

IL-2/IL-2R treatment facilitates Tregs neuroprotection of PCCs against OGD/R. OGD/R-exposed PCCs displayed significant cell death which was significantly reversed by both IL-2/IL-2R-Treg treatment and Treg treatment (*p < 0.0001), while cell viability with IL-2/IL-2R treatment alone was comparable to that of the media control treatment group (p > 0.05). Cell viability with the IL-2/IL-2R-Treg treatment was significantly higher than that of Treg treatment alone (*p < 0.0001)